glp-1 receptor agonist use and risk of suicide death A recent post hoc analysis published in Obesity found tirzepatide vs. placebo was not associated with increased depression symptoms. Rates of suicidal ideation behavior were low and similar to glp-1 receptor agonist use and
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 6 - Oct 11


























